This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Analgesics Market

Market Insights on Analgesics covering sales outlook, demand forecast & up-to-date key trends

Analgesics Market By Drug Class (Opioids, NSAIDs, Local Anesthetics, Acetaminophen), Indication (Surgical Pain, Cancer Pain, Neuropathic Pain), Route of Administration (Oral, Parenteral, Transdermal) & Region - Forecast 2021-2031

Analgesics Market Snapshot

[318 Pages Report] Analgesics Market to register 5.6% CAGR between 2021 and 2031, According to Future Market Insights (FMI). The total sales of analgesics are expected to reach US$ 77.3 Bn in 2021. As per FMI, opioids sales accounted for 50.3% of the market share in 2020.

Driven by positive demand outlook, the analgesics market held nearly 93% of sales in pain management market in 2020.

Data Points

Market Insights

Analgesics Market Estimated Value (2021)

US$ 77.3 Bn

Analgesics Market Estimated Value (2031)

US$ 133.5 Bn

CAGR 2021-2031

5.6%

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Analgesics Market: 2016 to 2020 Vs 2021 to 2031 Market Outlook

The global analgesics market expanded at 4.4% CAGR over the past 5 years. Analgesics is defined as a term which encompasses a class of drugs designed to provide pain relief without causing loss in consciousness. Opioid analgesics has been adopted worldwide and are recognized as the most effective and widely used drugs for the treatment of severe pain.

The global demand of analgesics arises from the goal of improving healthcare outcomes. This includes pain management, which requires a multidisciplinary approach to administer. Apart from this, the formulation of opioid analgesics with abuse-deterrent properties by manufacturers has created a high demand for analgesics over the globe.

Analgesics Market Download Report Brochure

  • According to the WHO, there are only about 14% of people over the globe who receive palliative care. Additionally, each year, the global estimation of people in need of palliative care is about 40 million. The low and middle-income economies carry over 78% of that population metric.

The global rise in the prevalence of neuropathic and chronic pain, as well as advancements in pain management measures are key factors pushing the global analgesics sales. The market is expected to expand at a CAGR of close to 5.6% over the forthcoming decade.  

What are the Key Opportunities for Analgesics Manufacturers?

Many people find a certain dose of opioids to be ineffective in cases of severe pain. These patients need to take a higher doses of drugs to subdue the pain, which eventually makes them opioid tolerant, and in some cases, addicted. Hence, commercializing opioid-tolerant drugs is expected to be one of the main opportunities for players in the opioid drugs market. This will also help in reducing the side effects related to or caused by increased consumption of opioid drugs.

For pain management, opioids are largely used in North America and Western Europe but due to increasing usage of opioids for non-medical purposes, the governing bodies of respective countries are encouraging doctors to prescribe non-opioid analgesics, which provides an opportunity for the companies to introduce novel non-opioid drugs.

The introduction of non-opioid analgesics in markets such as Asia and Africa, where the opioid as well as non-opioid drugs with novel drug delivery system are not widely available for pain management, creates opportunities for the growth of the analgesics market.

The rising cases of opioid dependency as well as the abuse of painkillers have led to the development of different forms of abuse-deterrent technologies. Expansion of manufacturing facilities across regions with scarce novel drug delivery systems will create opportunity for sales growth in the analgesics market over the forecast period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Sales of Analgesics?

Due to the severity of abusive opioids and their misuse, physicians have reduced their prescription for pain management, which has decreased their overall sales in the global analgesics market. According to the International Association for the Study of Pain (IASP), around 20–30% of opioids prescribed for chronic pain are being misused. Besides this, as per the association, up to 10% of the total opioid consumers are addicted to it.

The consumption of opioids per capita is low in Asian countries. As per the Global Opioids Policy Initiative (GOPI), factors responsible for the low usage of opioids in Asia and Africa are requirements of complete cost of payment by the patient, registration of patient receiving opioid prescription, unavailability of some opioid formulations and physician requirement to receive permission for opioid prescriptions.

These factors might restrain the analgesics market growth in the region.

Analgesics Market - Country-wise Insights

What Makes the U.S. Analgesics Market Dominant in North America?

The U.S. dominates the North America analgesics market with a total share of 86.5% in 2021, and is projected to continue exhibiting high demand through the course of the forecast period.

As per the documentations in 2016 by the National Health Institute, over 20% of adults in the U.S. suffer from chronic pain and 8% had high-impact chronic pain. This factor has leveraged analgesics demand in the country.

The Canadian Pain Task Force (CPTF) by the government of Canada was established in 2019 to deliver advice to guide the federal government towards better-quality methods for prevention and management of chronic pain, a diagnosis affecting nearly 8 million people living in Canada.

These initiatives will continue favoring expansion of the analgesics market in North America.

Why is Germany Analgesics Market Considered Lucrative within Europe?

Germany dominates the Europe analgesics market, with a share of 23.2%. Germany’s dominance is supported by the rising number of over the counter (OTC) pharmacies in the country.

The trend of self-medication in Germany is highly prevalent. Sales of non-prescription analgesics via OTC pharmacies in Germany has been characterized as one of the main drivers of sales of analgesics in the country.

What Makes China Analgesics Market Highly Attractive?

China holds 54.3% share in the East Asia market, and is projected to expand at a CAGR of over 9.3%. According to a research published in the Journal of Pharmaceutical Policy and Practice, evaluation of analgesic utilization in public hospitals in China presented a rapid increase in the utilization of analgesics in China. Furthermore, the utilization of NSAID’s and opioids showed a higher trend than other types of analgesics.

The introduction of non-opioid analgesics in the country is expected promote the sales of analgesics in China over the forecast period. 

What is the Japan Analgesics Market Outlook?

In 2020, Japan accounted for 31.8% of the East Asia analgesics market and is projected to expand at a CAGR of 6.6% from 2021 to 2031. There has been a swift trend favoring the demand aspect of analgesic utilization. Japan registered high sales of analgesics in 2018 and the demand was mostly concentrated in older or geriatric population aiming to achieve better quality of life.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Analgesics Market - Category-wise Insights

Which Analgesics Drug Class is Witnessing Maximum Demand?

By drug type, the demand for NSAID’s is projected to increase at a CAGR of 4.1% during the forecast period. High demand for this drug class is because of the rising burden of chronic pain and inflammation globally.

By Indication, Which Segment is leading the Analgesics Market?

Surgical pain holds a revenue share of 53.3% in 2021 and is projected to continue accounting for over half of sales in the market by 2031. This trend in market revenue share is associated with the increasing adoption of surgical procedures worldwide.

Which is the Preferred Distribution Channel for Analgesics Sales?

Based on distribution channel, hospital pharmacies led the analgesics market with more than 30.1% market share in 2020. The controlled sales of opioid analgesics contribute to a higher market share for hospital pharmacies.

Analgesics Market - Competitive Landscape

Key players are focusing on novel and innovative approaches for the development of non-opioid or non-addictive formulations for pain management.  The strategy of expansion, new product launches, and approvals, by key manufacturers is further strengthening their market presence.

  • In October 2017, Pfizer Inc., and other Leading health care organizations AmerisourceBergen, Blue Cross Blue Shield Association, and Prime Therapeutics are joining Walgreens (nation's largest drugstore chains) to combat the national opioid abuse crisis by expanding the availability of safe medication disposal kiosks to an additional 900 Walgreens stores.
  • In August 2018, Sun Pharma launched Volini Maxx, a pain relief spray.

Besides these, mergers and acquisitions have emerged as key growth strategies adopted by market players. Leading companies are strengthening their product portfolio and global footprint through acquisitions.

For instance:

  • In May 2020, Assertio Therapeutics, Inc. merged with Zyla Life Sciences. The merger created a growing commercial pharmaceutical company with neurology, inflammation, and pain products.

Report Scope as per Analgesics Industry Analysis

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Analgesics Market  Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

US, Canada,  Brazil,  Mexico, Germany, U.K., France, Italy, Spain,  Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, Turkey, South Africa, and GCC Countries

Key Market Segments Covered

Drug Class, Indication, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

  • Pfizer Inc.
  • Sun Pharmaceutical Industries, Inc.
  • Sanofi SA
  • AbbVie Inc. (Allergan plc)
  • Teva Pharmaceuticals
  • Boehringer Ingelheim International GmbH
  • Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
  • Endo Pharmaceuticals Inc.
  • Purdue Pharmaceuticals L.P.
  • Assertio Therapeutics, Inc.
  • Mallinckrodt Pharmaceuticals
  • Bayer AG
  • GlaxoSmithKline plc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Others

Pricing

Available upon Request           

Key Market Segments Covered in Analgesics Market Research

By Drug Class:

  • Opioids
    • Morphine
    • Codiene
    • Fentanyl
    • Meperidine
    • Methadone
    • Tramadol
    • Oxycodone
    • Dextromethorphan
    • Buprenorphine
    • Others
  • NSAIDs
  • Local Anesthetics
  • Acetaminophen

By Indication:

  • Surgical pain
  • Cancer Pain
  • Neuropathic pain
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Distribution Channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Drug Stores
  • Online pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

The global analgesics market is worth US$ 73.6 Bn at present, and is set to expand by ~1.7X over the next ten years.

The analgesics market is expected to reach US$ 133.6 Bn by the end of 2031, with sales revenue increasing at 5.6% CAGR.

From 2016-2020, the market for analgesics expanded at the rate of 4.4%, owing to rise in research and development opportunities with reference to non-opioid analgesics.

Commercialization of non-abuse opioids, adoption of opioids maintenance treatment (OMT) to treat opioids dependence (OD), and partnerships and collaborations for development of non-opioid analgesics are some of the key trends being witnessed in this marketplace.

The U.S., China, Canada, Germany and France are expected to drive demand for analgesics.

North America is one of the key markets for analgesics. The U.S. is expected to account over 85.7% of the North America market.

Demand for analgesics in Europe is expected to register growth at 5.3% CAGR over the next ten years.

The U.S., Germany and China are key producers of analgesics.

The China analgesics market will account for 54.3% in East Asia. Japan holds a revenue share of 31.8% in the region.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Development Trends

4. Key Success Factors

    4.1. Drug Adoption / Usage Analysis

    4.2. Key Strategies Adopted By Manufactures

    4.3. Regulatory Scenario 

5. Key Inclusion

    5.1. Number of Post-Operative Patients in U.S., Japan and Global

    5.2. Cross Sectional Analysis on Opioid Drug by Indication, U.S.

        5.2.1. Morphine

        5.2.2. Fentanyl

        5.2.3. Buprenorphine

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Growth Outlook

        6.1.2. Global Healthcare Outlook

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Increasing Prevalence of Chronic Disease and Surgical Procedures

        6.2.2. Increasing Prevalence of Neuropathic and Chronic pain

        6.2.3. Elevating Awareness about Palliative Care and Pain Management

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

    6.4. Value Chain Analysis

7. COVID19 Crisis Analysis

        7.1.1. Current COVID19 Statistics and Probable Future Impact

        7.1.2. Current GDP Projection and Probable Impact

        7.1.3. Current Economic Projection as compared to 2008 Economic analysis

        7.1.4. COVID19 and Impact Analysis

            7.1.4.1. Revenue By Product

            7.1.4.2. Revenue By Country

8. Global Analgesics Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031

    8.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    8.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, By Drug Class 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2021–2031

        9.3.1. Opioids

            9.3.1.1. Morphine

            9.3.1.2. Codeine

            9.3.1.3. Fentanyl

            9.3.1.4. Meperidine

            9.3.1.5. Methadone

            9.3.1.6. Tramadol

            9.3.1.7. Oxycodone

            9.3.1.8. Dextromethorphan

            9.3.1.9. Buprenorphine

            9.3.1.10. Others

        9.3.2. NSAIDs

        9.3.3. Local Anaesthetics

        9.3.4. Acetaminophen

    9.4. Market Attractiveness Analysis By Drug Class 

10. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Indication

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Indication, 2021 – 2031

        10.3.1. Surgical Pain

        10.3.2. Cancer Pain

        10.3.3. Neuropathic Pain

        10.3.4. Other 

    10.4. Market Attractiveness Analysis By Indications

11. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Route of Administration

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Route of Administration, 2021–2031

        11.3.1. Oral

        11.3.2. Parenteral

        11.3.3. Transdermal

        11.3.4. Others 

    11.4. Market Attractiveness Analysis By Route of Administration

12. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Distribution Channel 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016-2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2021–2031

        12.3.1. Hospitals

        12.3.2. Retail Pharmacies

        12.3.3. Drug Stores

        12.3.4. Online Pharmacies

    12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Analgesics Market Analysis 2016-2020 and Forecast 2021–2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021–2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis By Region

14. North America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        14.3.1. By Drug Class

        14.3.2. By Indication

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

        14.3.5. By Country

            14.3.5.1. U.S.

            14.3.5.2. Canada

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints-Impact Analysis

15. Latin America Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        15.3.1. By Drug Class

        15.3.2. By Indication

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

        15.3.5. By Country

            15.3.5.1. Brazil

            15.3.5.2. Mexico

            15.3.5.3. Argentina

            15.3.5.4. Rest of Latin America

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints-Impact Analysis

16. Europe Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        16.3.1. By Drug Class

        16.3.2. By Indication

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

        16.3.5. By Country

            16.3.5.1. Germany

            16.3.5.2. Italy

            16.3.5.3. France

            16.3.5.4. U.K.

            16.3.5.5. Spain

            16.3.5.6. BENELUX

            16.3.5.7. Russia

            16.3.5.8. Rest of Europe

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints-Impact Analysis

17. South Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        17.3.1. By Drug Class

        17.3.2. By Indication

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

        17.3.5. By Country

            17.3.5.1. India

            17.3.5.2. Thailand

            17.3.5.3. Indonesia

            17.3.5.4. Malaysia

            17.3.5.5. Rest of South Asia

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints-Impact Analysis

18. East Asia Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        18.3.1. By Drug Class

        18.3.2. By Indication

        18.3.3. By Route of Administration

        18.3.4. By Distribution Channel

        18.3.5. By Country

            18.3.5.1. China

            18.3.5.2. Japan 

            18.3.5.3. South Korea 

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints-Impact Analysis

19. Oceania Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        19.3.1. By Drug Class

        19.3.2. By Indication

        19.3.3. By Route of Administration

        19.3.4. By Distribution Channel

        19.3.5. By Country

            19.3.5.1. Australia

            19.3.5.2. New Zealand

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints-Impact Analysis

20. Middle East and Africa Analgesics Market Analysis 2016-2020 and Forecast 2021–2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021–2031

        20.3.1. By Drug Class

        20.3.2. By Indication

        20.3.3. By Route of Administration

        20.3.4. By Distribution Channel

        20.3.5. By Country

            20.3.5.1. GCC Countries

            20.3.5.2. Turkey

            20.3.5.3. Northern Africa

            20.3.5.4. South Africa

            20.3.5.5. Rest of Middle East and Africa

    20.4. Market Attractiveness Analysis

    20.5. Drivers and Restraints-Impact Analysis

21. Key and Emerging Countries Analgesics Market Analysis 

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Analgesics Market Analysis

        21.2.1. By Drug Class

        21.2.2. By Indication

        21.2.3. By Route of Administration

        21.2.4. By Distribution Channel

    21.3. Canada Analgesics Market Analysis

        21.3.1. By Drug Class

        21.3.2. By Indication

        21.3.3. By Route of Administration

        21.3.4. By Distribution Channel

    21.4. Mexico Analgesics Market Analysis

        21.4.1. By Drug Class

        21.4.2. By Indication

        21.4.3. By Route of Administration

        21.4.4. By Distribution Channel

    21.5. Brazil Analgesics Market Analysis

        21.5.1. By Drug Class

        21.5.2. By Indication

        21.5.3. By Route of Administration

        21.5.4. By Distribution Channel

    21.6. Germany Analgesics Market Analysis

        21.6.1. By Drug Class

        21.6.2. By Indication

        21.6.3. By Route of Administration

        21.6.4. By Distribution Channel

    21.7. Italy Analgesics Market Analysis

        21.7.1. By Drug Class

        21.7.2. By Indication

        21.7.3. By Route of Administration

        21.7.4. By Distribution Channel

    21.8. France Analgesics Market Analysis

        21.8.1. By Drug Class

        21.8.2. By Indication

        21.8.3. By Route of Administration

        21.8.4. By Distribution Channel

    21.9. U.K. Analgesics Market Analysis

        21.9.1. By Drug Class

        21.9.2. By Indication

        21.9.3. By Route of Administration

        21.9.4. By Distribution Channel

    21.10. Spain Analgesics Market Analysis

        21.10.1. By Drug Class

        21.10.2. By Indication

        21.10.3. By Route of Administration

        21.10.4. By Distribution Channel

    21.11. BENELUX Analgesics Market Analysis

        21.11.1. By Drug Class

        21.11.2. By Indication

        21.11.3. By Route of Administration

        21.11.4. By Distribution Channel

    21.12. Russia Analgesics Market Analysis

        21.12.1. By Drug Class

        21.12.2. By Indication

        21.12.3. By Route of Administration

        21.12.4. By Distribution Channel

    21.13. China Analgesics Market Analysis

        21.13.1. By Drug Class

        21.13.2. By Indication

        21.13.3. By Route of Administration

        21.13.4. By Distribution Channel

    21.14. Japan Analgesics Market Analysis

        21.14.1. By Drug Class

        21.14.2. By Indication

        21.14.3. By Route of Administration

        21.14.4. By Distribution Channel

    21.15. South Korea Analgesics Market Analysis

        21.15.1. By Drug Class

        21.15.2. By Indication

        21.15.3. By Route of Administration

        21.15.4. By Distribution Channel

    21.16. India Analgesics Market Analysis

        21.16.1. By Drug Class

        21.16.2. By Indication

        21.16.3. By Route of Administration

        21.16.4. By Distribution Channel

    21.17. ASEAN Analgesics Market Analysis

        21.17.1. By Drug Class

        21.17.2. By Indication

        21.17.3. By Route of Administration

        21.17.4. By Distribution Channel

    21.18. Australia Analgesics Market Analysis

        21.18.1. By Drug Class

        21.18.2. By Indication

        21.18.3. By Route of Administration

        21.18.4. By Distribution Channel

    21.19. New Zealand Analgesics Market Analysis

        21.19.1. By Drug Class

        21.19.2. By Indication

        21.19.3. By Route of Administration

        21.19.4. By Distribution Channel

    21.20. GCC Countries Analgesics Market Analysis

        21.20.1. By Drug Class

        21.20.2. By Indication

        21.20.3. By Route of Administration

        21.20.4. By Distribution Channel

    21.21. Turkey Analgesics Market Analysis

        21.21.1. By Drug Class

        21.21.2. By Indication

        21.21.3. By Route of Administration

        21.21.4. By Distribution Channel

    21.22. South Africa Analgesics Market Analysis

        21.22.1. By Drug Class

        21.22.2. By Indication

        21.22.3. By Route of Administration

        21.22.4. By Distribution Channel

22. Market Structure Analysis

    22.1. Market Share Analysis

    22.2. Market Analysis by Tier of Companies 

    22.3. Market Concentration

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Deep Dive 

        23.2.1. Pfizer Inc.

            23.2.1.1. Overview

            23.2.1.2. Product Offering

            23.2.1.3. Regional Footprint

            23.2.1.4. Strategy Overview

                23.2.1.4.1. Marketing Strategy

                23.2.1.4.2. Product Strategy

                23.2.1.4.3. Channel Strategy

        23.2.2. Sun Pharmaceutical Industries, Inc.

            23.2.2.1. Overview

            23.2.2.2. Product Offering

            23.2.2.3. Regional Footprint

            23.2.2.4. Strategy Overview

                23.2.2.4.1. Marketing Strategy

                23.2.2.4.2. Product Strategy

                23.2.2.4.3. Channel Strategy

        23.2.3. Sanofi SA

            23.2.3.1. Overview

            23.2.3.2. Product Offering

            23.2.3.3. Regional Footprint

            23.2.3.4. Strategy Overview

                23.2.3.4.1. Marketing Strategy

                23.2.3.4.2. Product Strategy

                23.2.3.4.3. Channel Strategy

        23.2.4. AbbVie Inc. (Allergan plc) 

            23.2.4.1. Overview

            23.2.4.2. Product Offering

            23.2.4.3. Regional Footprint

            23.2.4.4. Strategy Overview

                23.2.4.4.1. Marketing Strategy

                23.2.4.4.2. Product Strategy

                23.2.4.4.3. Channel Strategy

        23.2.5.  Teva Pharmaceuticals 

            23.2.5.1. Overview

            23.2.5.2. Product Offering

            23.2.5.3. Regional Footprint

            23.2.5.4. Strategy Overview

                23.2.5.4.1. Marketing Strategy

                23.2.5.4.2. Product Strategy

                23.2.5.4.3. Channel Strategy

        23.2.6. Boehringer Ingelheim International GmbH 

            23.2.6.1. Overview

            23.2.6.2. Product Offering

            23.2.6.3. Regional Footprint

            23.2.6.4. Strategy Overview

                23.2.6.4.1. Marketing Strategy

                23.2.6.4.2. Product Strategy

                23.2.6.4.3. Channel Strategy

        23.2.7. Janssen Pharmaceuticals, Inc. [Johnson & Johnson] 

            23.2.7.1. Overview

            23.2.7.2. Product Offering

            23.2.7.3. Regional Footprint

            23.2.7.4. Strategy Overview

                23.2.7.4.1. Marketing Strategy

                23.2.7.4.2. Product Strategy

                23.2.7.4.3. Channel Strategy

        23.2.8. Endo Pharmaceuticals Inc. 

            23.2.8.1. Overview

            23.2.8.2. Product Offering

            23.2.8.3. Regional Footprint

            23.2.8.4. Strategy Overview

                23.2.8.4.1. Marketing Strategy

                23.2.8.4.2. Product Strategy

                23.2.8.4.3. Channel Strategy

        23.2.9. Purdue Pharmaceuticals L.P. 

            23.2.9.1. Overview

            23.2.9.2. Product Offering

            23.2.9.3. Regional Footprint

            23.2.9.4. Strategy Overview

                23.2.9.4.1. Marketing Strategy

                23.2.9.4.2. Product Strategy

                23.2.9.4.3. Channel Strategy

        23.2.10. Assertio Therapeutics, Inc.

            23.2.10.1. Overview

            23.2.10.2. Product Offering

            23.2.10.3. Regional Footprint

            23.2.10.4. Strategy Overview

                23.2.10.4.1. Marketing Strategy

                23.2.10.4.2. Product Strategy

                23.2.10.4.3. Channel Strategy 

        23.2.11. Mallinckrodt Pharmaceuticals 

            23.2.11.1. Overview

            23.2.11.2. Product Offering

            23.2.11.3. Regional Footprint

            23.2.11.4. Strategy Overview

                23.2.11.4.1. Marketing Strategy

                23.2.11.4.2. Product Strategy

                23.2.11.4.3. Channel Strategy

        23.2.12. Bayer AG 

            23.2.12.1. Overview

            23.2.12.2. Product Offering

            23.2.12.3. Regional Footprint

            23.2.12.4. Strategy Overview

                23.2.12.4.1. Marketing Strategy

                23.2.12.4.2. Product Strategy

                23.2.12.4.3. Channel Strategy

        23.2.13. GlaxoSmithKline plc. 

            23.2.13.1. Overview

            23.2.13.2. Product Offering

            23.2.13.3. Regional Footprint

            23.2.13.4. Strategy Overview

                23.2.13.4.1. Marketing Strategy

                23.2.13.4.2. Product Strategy

                23.2.13.4.3. Channel Strategy

        23.2.14. Bausch Health Companies Inc.

            23.2.14.1. Overview

            23.2.14.2. Product Offering

            23.2.14.3. Regional Footprint

            23.2.14.4. Strategy Overview

                23.2.14.4.1. Marketing Strategy

                23.2.14.4.2. Product Strategy

                23.2.14.4.3. Channel Strategy

        23.2.15. Novartis AG 

            23.2.15.1. Overview

            23.2.15.2. Product Offering

            23.2.15.3. Regional Footprint

            23.2.15.4. Strategy Overview

                23.2.15.4.1. Marketing Strategy

                23.2.15.4.2. Product Strategy

                23.2.15.4.3. Channel Strategy

        23.2.16. Others

            23.2.16.1. Overview

            23.2.16.2. Product Offering

            23.2.16.3. Regional Footprint

            23.2.16.4. Strategy Overview

                23.2.16.4.1. Marketing Strategy

                23.2.16.4.2. Product Strategy

                23.2.16.4.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

 

Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 04: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 05: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 06: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel 

Table 07: Global Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 08: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 09: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 10: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 11: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 12: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 13: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 14: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 15: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 16: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 17: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 18: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 19: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 20: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 21: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 22: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 23: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 24: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 25: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 26: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 27: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 28: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 29: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 30: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 31: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 32: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 33: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 34: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 35: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 36: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 37: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 38: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 39: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Drug Class

Table 40: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 41: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 42: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01 : Global Analgesics Market Value (US$ Mn) Forecast, 2021 – 2031

Figure 02 : Global Analgesics Market Share, By Drug Class (2021)

Figure 03 : Global Analgesics Market Share, By Region (2021)

Figure 04: Global Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 05: Global Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2021-2031

Figure 06: Global Analgesics Market Absolute $ Opportunity Analysis, 2021-2031

Figure 07: Global Analgesics Market Analysis By Drug Class–2021 & 2031

Figure 08: Global Analgesics Market Y-o-Y Growth Projections By Drug Class, 2021-2031

Figure 09: Global Analgesics Market Attractiveness, By Drug Class

Figure 10: Global Analgesics Market Analysis By Indication–2021 & 2031

Figure 11: Global Analgesics Market Y-o-Y Growth Projections By Indication, 2021-2031

Figure 12: Global Analgesics Market Attractiveness, By Indication

Figure 13: Global Analgesics Market Analysis By Route of Administration – 2021 & 2031

Figure 14: Global Analgesics Market Y-o-Y Growth Projections By Route of Administration, 2021-2031

Figure 15: Global Analgesics Market Attractiveness, By Route of Administration 

Figure 16: Global Analgesics Market Analysis By Distribution Channel–2021 & 2031

Figure 17: Global Analgesics Market Y-o-Y Growth Projections By Distribution Channel, 2021-2031

Figure 18: Global Analgesics Market Attractiveness, By Distribution Channel 

Figure 19: Global Analgesics Market Analysis by Region–2021 & 2031

Figure 20: Global Analgesics Market Y-o-Y Growth Projections by Region, 2021-2031

Figure 21: Global Analgesics Market Attractiveness, By Region

Figure 22: North America Analgesics Market Share, By Drug Class, 2021 (E)

Figure 23: North America Analgesics Market Share, By Indication, 2021 (E)

Figure 24: North America Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 25: North America Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 26: North America Analgesics Market Share, By Country, 2021 (E)

Figure 27: North America Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 28: North America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 29: North America Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 30: North America Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 31: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 32: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 33: North America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 34: Latin America Analgesics Market Share, By Drug Class, 2021 (E)

Figure 35: Latin America Analgesics Market Share, By Indication, 2021 (E)

Figure 36: Latin America Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 37: Latin America Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 38: Latin America Analgesics Market Share, By Country, 2021 (E)

Figure 39: Latin America Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 40: Latin America Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 41: Latin America Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 42: Latin America Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 43: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 44: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 45: Latin America Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 46: Europe Analgesics Market Share, By Drug Class, 2021 (E)

Figure 47: Europe Analgesics Market Share, By Indication, 2021 (E)

Figure 48: Europe Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 49: Europe Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 50: Europe Analgesics Market Share, By Country, 2021 (E)

Figure 51: Europe Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 52: Europe Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 53: Europe Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 54: Europe Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 55: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 56: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 57: Europe Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 58: South Asia Analgesics Market Share, By Drug Class, 2021 (E)

Figure 59: South Asia Analgesics Market Share, By Indication, 2021 (E)

Figure 60: South Asia Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 61: South Asia Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 62: South Asia Analgesics Market Share, By Country, 2021 (E)

Figure 63: South Asia Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 64: South Asia Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 65: South Asia Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 66: South Asia Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 67: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 68: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 69: South Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 70: East Asia Analgesics Market Share, By Drug Class, 2021 (E)

Figure 71: East Asia Analgesics Market Share, By Indication, 2021 (E)

Figure 72: East Asia Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 73: East Asia Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 74: East Asia Analgesics Market Share, By Country, 2021 (E)

Figure 75: East Asia Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 76: East Asia Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 77: East Asia Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 78: East Asia Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 79: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 80: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 81: East Asia Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 82: Oceania Analgesics Market Share, By Drug Class, 2021 (E)

Figure 83: Oceania Analgesics Market Share, By Indication, 2021 (E)

Figure 84: Oceania Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 85: Oceania Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 86: Oceania Analgesics Market Share, By Country, 2021 (E)

Figure 87: Oceania Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 88: Oceania Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 89: Oceania Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 90: Oceania Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 91: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 92: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 93: Oceania Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 94: MEA Analgesics Market Share, By Drug Class, 2021 (E)

Figure 95: MEA Analgesics Market Share, By Indication, 2021 (E)

Figure 96: MEA Analgesics Market Share, By Route of Administration, 2021 (E)

Figure 97: MEA Analgesics Market Share, By Distribution Channel, 2021 (E)

Figure 98: MEA Analgesics Market Share, By Country, 2021 (E)

Figure 99: MEA Analgesics Market Size (US$ Mn) Analysis, 2016-2020

Figure 100: MEA Analgesics Market Size (US$ Mn) & Y-o-Y Growth (%), 2021-2031

Figure 101: MEA Analgesics Market Attractiveness Analysis 2021-2031 By Country

Figure 102: MEA Analgesics Market Attractiveness Analysis 2021-2031 By Drug Class

Figure 103: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Figure 104: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 105: MEA Analgesics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 106: Global Analgesics Market Value Proportion Analysis, By Emerging Countries, 2020

Figure 107: Analgesics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031

Figure 108: U.S. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 109: U.S. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 110: U.S. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 111: U.S. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 112: Canada Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 113: Canada Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 114: Canada. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 115: Canada. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 116: Brazil. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 117: Brazil. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 118: Brazil. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 119: Brazil. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 120: Mexico. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 121: Mexico. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 122: Mexico. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 123: Mexico. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 124: UK. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 125: UK. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 126: UK. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 127: UK. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 128: Germany. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 129: Germany. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 130: Germany. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 131: Germany. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 132: Italy. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 133: Italy. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 134: Italy. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 135: Italy. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 136: France. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 137: France. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 138: France. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 139: France. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 140: Spain. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 141: Spain. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 142: Spain. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 143: Spain. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 144: Russia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 145: Russia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 146: Russia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 147: Russia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 148: BENELUX Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 149: BENELUX Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 150: BENELUX Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 151: BENELUX Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 152: China. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 153: China. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 154: China. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 155: China. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 156: Japan. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 157: Japan. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 158: Japan. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 159: Japan. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 160: South Korea. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 161: South Korea. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 162: South Korea. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 163: South Korea. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 164: India. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 165: India. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 166: India. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 167: India. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 168: Thailand. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 169: Thailand. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 170: Thailand. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 171: Thailand. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 172: Indonesia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 173: Indonesia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 174: Indonesia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 175: Indonesia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 176: Malaysia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 177: Malaysia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 178: Malaysia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 179: Malaysia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 180: Australia. Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 181: Australia. Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 182: Australia. Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 183: Australia. Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 184: New Zealand Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 185: New Zealand Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 186: New Zealand Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 187: New Zealand Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 188: Turkey Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 189: Turkey Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 190: Turkey Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 191: Turkey Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 192: GCC Countries Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 193: GCC Countries Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 194: GCC Countries Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 195: GCC Countries Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 196: South Africa Analgesics Market Share Analysis (%) By Drug Class, 2021 & 2031

Figure 197: South Africa Analgesics Market Share Analysis (%) By Indication, 2021 & 2031

Figure 198: South Africa Analgesics Market Share Analysis (%) By Route of Administration, 2021 & 2031

Figure 199: South Africa Analgesics Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Opioid Analgesics Market

Published : October 2021

Healthcare

Non-opioid Pain Patches Market

Published : February 2022

Healthcare

Prefilled Syringes Drug Molecules Market

Published : January 2022

Healthcare

Analgesics Market

Published : December 2021

Google translate